Two things I reckon - some growth in that stagnant $40m annualised revenue and continued repayment of debt, leading to more free cashflow.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game